Peptide reference materials

for laboratory research and

scientific investigation.

RESEARCH-GRADE PEPTIDES

Signals the cell already knows how to read.

Research peptides supported by published scientific literature, technical specifications and independently verified analytical data where available.

SCROLL TO BEGIN SWIPE UP TO BEGIN

GLY–HIS–LYS · Cu²⁺

GHK-Cu 100mg

MW 403.9 · TRIPEPTIDE–COPPER COMPLEX

GHK-Cu is a naturally occurring copper-binding tripeptide investigated in laboratory models of extracellular matrix regulation, collagen-related signalling and tissue remodelling. Findings are dependent on experimental conditions and do not establish clinical effectiveness.

Copper-binding tripeptide investigated in laboratory models of matrix regulation and tissue remodelling.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

GEPPPGKPADDAGLV

BPC-157 10mg

MW 1419.5 · 15 RESIDUES · PENTADECAPEPTIDE

BPC-157 is a synthetic pentadecapeptide investigated in preclinical models involving tissue responses, angiogenic signalling and gastrointestinal physiology. Most published efficacy evidence is preclinical, and therapeutic safety and effectiveness in humans have not been established.

Synthetic pentadecapeptide investigated in preclinical models. Human safety and effectiveness not established.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

Ac-LKKTETQ

TB-500 10mg

MW 889.0 · THYMOSIN β4-ASSOCIATED FRAGMENT

TB-500 is a synthetic peptide associated with a fragment of thymosin beta-4 and investigated in molecular and cellular research. Findings involving full-length thymosin beta-4 cannot automatically be attributed to the shorter peptide fragment.

Synthetic peptide associated with a thymosin β4 fragment, investigated in molecular and cellular research.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

LY3437943

Retatrutide 10mg

MW 4731 · GLP-1 / GIP / GLUCAGON TRIAGONIST

Retatrutide (LY3437943) is an investigational peptide designed to activate GLP-1, GIP and glucagon receptors. It has been evaluated in clinical research investigating metabolic and weight-related outcomes. Clinical development and regulatory status are subject to change.

Investigational GLP-1 / GIP / glucagon receptor agonist evaluated in clinical research.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

trans-3-HEXENOYL-hGRF(1–44)-NH₂

Tesamorelin 20mg

MW 5135.9 · 44 RESIDUES · GHRH ANALOGUE

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH). Specific pharmaceutical formulations have received US regulatory approval for defined medical indications. These approvals do not apply to independently supplied research-grade preparations.

Synthetic GHRH analogue. Approvals for specific formulations do not apply to research preparations.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

MRWQEMGYIFYPRKLR

MOTS-c 40mg

MW 2174.6 · 16 RESIDUES · MITOCHONDRIAL-DERIVED PEPTIDE

MOTS-c is a mitochondrial-derived peptide investigated in preclinical studies involving metabolic regulation, cellular stress responses and AMPK-associated signalling. Its safety and clinical effectiveness in humans remain insufficiently established.

Mitochondrial-derived peptide investigated in preclinical studies of metabolic regulation.

Powder + free BAC water3ml included with every vial

3+ vials
20% off

Learn more

What this site is, and what it isn’t.

Scope

Quadra Biotech supplies reference materials to laboratories, universities and contract research organisations. Products are intended exclusively for legitimate laboratory research. They are not intended for human or veterinary administration, clinical treatment, supplementation or self-experimentation. Scientific descriptions are provided for research information and do not constitute medical advice or establish therapeutic safety or efficacy.

Evidence

Each compound carries its evidence status in the same viewport as its name: approved formulation, topical, investigational or preclinical. Preclinical evidence is kept distinct from human clinical findings. Where the literature is thin, we say so. Where a mechanism is described, it is cited to a primary source you can read yourself.

Limits

We publish no dosing, no administration routes and no protocols. Storage and reconstitution conditions only. Regulatory status varies by compound, formulation, intended use and jurisdiction. Any approvals granted to pharmaceutical products do not extend automatically to the research materials supplied by Quadra Biotech.

Quadra Biotech makes no therapeutic claims. Product availability and shipping eligibility depend on the selected destination, applicable regulations and purchaser eligibility. Orders may be declined where lawful supply cannot be established. Research use & product information.